Tvardi Therapeutics (TVRD) director granted 6,000 options at $2.78 exercise price
Rhea-AI Filing Summary
Tvardi Therapeutics, Inc. director Cynthia Smith reported receiving a grant of stock options as equity compensation. The award covers 6,000 options to buy Tvardi common stock at an exercise price of $2.78 per share, expiring on June 8, 2036.
All 6,000 underlying shares vest in a single tranche on the earlier of June 9, 2027 or the date of Tvardi’s next annual meeting of stockholders, provided she remains in continuous service through that vesting date. Following this grant, she holds 6,000 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Smith Cynthia
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 6,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 6,000 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 6,000 options
Exercise price: $2.78 per share
Expiration date: June 8, 2036
+2 more
5 metrics
Options granted
6,000 options
Stock Option grant to director Cynthia Smith
Exercise price
$2.78 per share
Exercise price for 6,000 stock options
Expiration date
June 8, 2036
Option grant expiration date
Vesting trigger date
June 9, 2027
Earlier of this date or next annual meeting, subject to service
Shares underlying options
6,000 shares
Underlying Tvardi common stock for this option grant
Key Terms
Stock Option (right to buy), Common Stock, Grant, award, or other acquisition, exercise price, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 2.7800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
continuous service financial
"subject to the Reporting Person's continuous service through such vesting date"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Tvardi Therapeutics (TVRD) director Cynthia Smith report?
Cynthia Smith reported receiving a grant of stock options for 6,000 shares of Tvardi Therapeutics common stock. These options are a compensation award, not an open-market stock purchase or sale, and are exercisable at a fixed price if they vest.
How many Tvardi Therapeutics (TVRD) options did Cynthia Smith receive and at what price?
She received 6,000 stock options with an exercise price of $2.78 per share. This means she can buy up to 6,000 Tvardi common shares at $2.78 if the options vest and she chooses to exercise them before expiration.
When do Cynthia Smith’s Tvardi Therapeutics (TVRD) options vest?
All 6,000 options vest 100% on the earlier of June 9, 2027 or Tvardi’s next annual meeting of stockholders. Vesting is conditioned on her continuous service with the company through the applicable vesting date, according to the filing footnote.
When do Cynthia Smith’s Tvardi Therapeutics (TVRD) stock options expire?
The options expire on June 8, 2036 if not exercised earlier. After the expiration date, she would no longer have the right to purchase Tvardi common stock under this particular 6,000-share option grant at the fixed $2.78 exercise price.
Does Cynthia Smith’s Tvardi Therapeutics (TVRD) Form 4 show any stock sales or purchases?
The Form 4 reports only a grant of 6,000 stock options as a compensation award. It does not show any open-market purchases or sales of Tvardi common stock, and the transaction code indicates a grant or other acquisition of a derivative security.